1. Application of the OMERACT Grey-scale Ultrasound Scoring System for salivary glands in a single-centre cohort of patients with suspected Sjögren’s syndrome
- Author
-
Lene Terslev, Viktoria Fana, Simon Krabbe, and Uffe Møller Døhn
- Subjects
musculoskeletal diseases ,medicine.medical_specialty ,Scoring system ,Immunology ,Physical examination ,Grey scale ,Sensitivity and Specificity ,Salivary Glands ,Rheumatology ,stomatognathic system ,Internal medicine ,Biopsy ,medicine ,Immunology and Allergy ,Humans ,Parotid Gland ,autoimmune diseases ,medicine.diagnostic_test ,Salivary gland ,Sjögren Syndrome ,business.industry ,Ultrasound ,ultrasonography ,stomatognathic diseases ,medicine.anatomical_structure ,Sjogren's Syndrome ,Sjogren's syndrome ,Cohort ,Medicine ,Radiology ,business - Abstract
AimTo describe salivary gland involvement in patients suspected of Sjögren’s syndrome (SS) using the OMERACT Ultrasound Scoring System for SS. Next, using different ultrasound cut-offs, to assess the performance of the scoring system for diagnosis and fulfilment of 2016 ACR/EULAR SS classification criteria.MethodsAll patients referred to our department with a suspicion of SS in a 12-month period were included. All underwent grey-scale ultrasound of the parotid and submandibular glands prior to clinical examination, Schirmer’s test, unstimulated salivary flow, blood samples including autoantibody analysis. Labial biopsy was performed according to clinicians’ judgement. Images of the four glands were scored 0–3 according to the scoring system and a consensus score was obtained using a developed ultrasound atlas.ResultsOf the 134 patients included in the analysis, 43 were diagnosed with primary SS (pSS) and all fulfilled the 2016 American College of Rheumatology (ACR)/EULAR classification criteria. More patients with pSS compared with non-pSS had score ≥2 in at least one gland (72% vs 13%; pConclusionThe OMERACT Ultrasound Scoring System showed good sensitivity (0.72) and excellent specificity (0.91) for fulfilling 2016 ACR/EULAR criteria using cut-off score >2 in at least one gland. Our data supports the use of ultrasound for diagnosing pSS and supports incorporation of ultrasound in the classification criteria.
- Published
- 2021